Homeapotherapy research desk Find my starting point

Product fact sheet

Align 24/7 Digestive Support

Evidence-aware Align probiotic fact sheet for Bifidobacterium 35624, including positive IBS evidence, a neutral non-patient trial and strain-identity testing.

Probiotics by strain and evidenceCompare strain or formulation identity, dose, indication-specific evidence and safety context. Compare in context → Probiotics, prebiotics and digestive enzymesSee this product in the broader digestive-supplement decision. Compare in context → Side-by-side probiotic comparisonOpen the comparison surface for this product family; missing comparable data is shown rather than guessed. Compare products →
Strain clinical evidence mixedFacts checked 2026-08-11

A rare consumer probiotic with a clearly identified strain (Bifidobacterium 35624) linked to randomized evidence, including a positive IBS trial and a separate neutral symptom-severity trial in a non-patient population.

Fit signals

People comparing probiotics by exact strain rather than CFU marketing, Readers who want positive and negative strain evidence shown together

Potential constraints

Severely ill or immunocompromised people without clinician guidance, Anyone assuming a higher CFU count is automatically better

Key tradeoff: Far better strain transparency than generic blends, but benefits are indication-, population- and dose-specific.

This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.

Align 24/7 Digestive Support identifies Bifidobacterium 35624, which makes it much easier to map the retail product to strain-level research than a probiotic labeled only with a proprietary blend.

Positive strain evidence

A randomized trial in 362 women with irritable bowel syndrome found that a specific dose of Bifidobacterium 35624 improved abdominal pain/discomfort and several other symptoms compared with placebo.

That is relevant evidence for the strain in an IBS population at the studied dose.

The important negative counterweight

A separate randomized study in people without IBS who reported abdominal discomfort and bloating did not find a significant improvement in mean symptom severity versus placebo, although some secondary measures differed.

The right conclusion is not “works” or “doesn’t work.” It is: do not generalize an IBS result to every person with bloating.

Product quality

The manufacturer states that each lot is DNA tested for strain identity. The current retail viability claim should still be compared carefully with the dose and viable count used in the relevant trial.

Probiotic use also deserves additional caution in people who are severely ill or immunocompromised.

Read Probiotics, Prebiotics & Digestive Enzymes for the strain-first framework.

Formula facts

Ingredients, actives and label details

Strain
Bifidobacterium 35624 (historically described as B. infantis 35624)
Basis: Manufacturer Source: Align 24/7 Digestive Support Probiotic Supplement
Viable count
Manufacturer states 1 billion CFU at manufacture and at least 10 million CFU through best-by date for flagship capsules
Basis: Manufacturer Source: Align 24/7 Digestive Support Probiotic Supplement
Identity testing
Manufacturer states each lot is DNA tested for strain identity
Basis: Manufacturer Source: Align 24/7 Digestive Support Probiotic Supplement
Positive trial signal
In 362 women with IBS, 1 x 10^8 CFU improved abdominal pain/discomfort and several secondary symptoms versus placebo
Basis: Randomized controlled trial Source: Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome
Failed / neutral endpoint
In 302 non-patients with abdominal discomfort/bloating, mean symptom severity was not significantly better than placebo
Basis: Randomized controlled trial negative Source: Bifidobacterium infantis 35624 in non-patients with abdominal discomfort and bloating
Safety context
Probiotics require extra caution in severely ill or immunocompromised people
Basis: Government evidence review Source: Probiotics - Health Professional Fact Sheet

Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.

Safety first

What should make you slow down?

Use the product as directed, avoid treating concentrated wellness products as automatically harmless, and ask a qualified clinician when your situation or medication use makes the decision less routine.

Where to buy

Current tracked merchants

Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.

Source trail

Primary documents and supporting evidence

  1. Align 24/7 Digestive Support Probiotic SupplementAlign · Manufacturer · retrieved 2026-08-11
  2. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndromeAmerican Journal of Gastroenterology / PubMed · Randomized controlled trial · retrieved 2026-08-11
  3. Bifidobacterium infantis 35624 in non-patients with abdominal discomfort and bloatingPubMed · Randomized controlled trial negative · retrieved 2026-08-11
  4. Probiotics - Health Professional Fact SheetNIH Office of Dietary Supplements · Government evidence review · retrieved 2026-08-11